Abstract
Vaccination against influenza and Streptococcus pneumoniae is recommended for elderly and immunocompromised individuals. However, there is little information concerning the efficacy of vaccination in specific groups of patients. In this study, 52 patients underwent vaccination against influenza, S. pneumoniae and Haemophilus influenzae type b (Hib) as they attended hospital outpatient clinics. Serum was analysed prior to vaccination and 4–6 weeks afterwards. Antibody titres against S. pneumoniae and Hib were compared with reference values corresponding to the geometric mean titres of a healthy UK population. For influenza vaccination, haemagglutination inhibition (HI) titres were measured against three inactivated strains; a titre of ≥ 1/40 was considered protective. No patient had protective titres to all three antigens prior to vaccination and 41 patients (85%) had titres < 1/40 to all 3 strains. Post vaccination only 9/48 patients (19%) achieved protective antibody titres. Resistance to S. pneumoniae and response to Pneumovax II was also poor: prevaccination, 45 patients (93%) had suboptimal antibody titres and in 26/43 patients (61%) titres remained low post vaccination. Resistance to Hib and response to vaccination was comparable with the healthy adult UK population. These results question the practice of routine influenza and pneumococcal vaccination in myeloma patients. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Admon D, Engelhard D, Strauss N, Goldman N and Zakay-Rones Z (1997) Antibody response to influenza immunization in patients after heart transplantation. Vaccine 15: 1518–1522
Ahmed AH, Nicholson KG and Nguyen van Tam JS (1995) Reduction in mortality associated with influenza vaccination during 1989–90 epidemic. Lancet 346: 591–595
Anderson H, Petrie K, Berrisford C, Charlett A, Thatcher N and Zambon M (1999) Seroconversion after influenza vaccination in patients with lung cancer. Br J Cancer 80: 219–220
Brydak LB, Rokicka-Milewska R, Machala M, Jackowska T and Sikorskå-Fic B (1998) Immunogenicity of subunit trivalent influenza vaccine in children with acute lymphoblastic leukaemia. Paediatr Infect Dis J 17: 126–129
Chakraverty P (1971) Antigenic relationships between influenza B viruses. Bull WHO 45: 755–766
Dedman DJ, Zambon M, Van Buynder P, Fleming DM, Watson JM and Joseph CA (1998) Influenza surveillance in England and Wales: October 1997 to June 1998. Commun Dis Public Health 1: 244–251
Deresinski SC and Stevens DA (1974) Disseminated herpes simplex in untreated multiple myeloma. Paradox of present concepts of immune defects. Oncology 30: 318–323
Fahey J, Scoggin R, Utz J and Szwed C (1963) Infection, antibody response and gamma globulin components in myeloma and macroglobulinaemia. Am J Med 35: 698–707
Gribabis DA, Panayiotidis P, Boussiotis VA, Hannoun C and Pangalis GA (1994) Influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients. Acta Haematol 91: 115–118
Hazelwood M, Nusrat R, Kumararatne DS, Goodall M, Raykundalia C, Gong Wang D, Joyce HJ, Milford-Wards A, Forte M and Pahor A (1993) The acquisition of anti-pneumococcal capsular polysaccharide, Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK. Clin Exp Immunol 93: 1–8
HMSO (1996) Immunisation against Infectious Disease. Department of Health: London
Honkanen PO, Keistinen T and Kivela SL (1996) Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly. Arch Intern Med 156: 205–206
Iorio AM, Alatri A, Francisci D, Preziosi R, Neri M, Donatelli I, Castrucci MR, Biasio LR, Tascini C, Iapoce R, Pierucci P and Baldelli F (1997) Immunogenicity of influenza vaccine (1993–94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users. Vaccine 15: 97–102
Jackson LA, Benson P, Sneller VP, Butler JC, Thompson RS, Chen RT, Lewis LS, Carlone G, De Stefano F, Holder P, Lezhava T and Williams WW (1999) Safety of revaccination with pneumococcal polysaccharide vaccine. J Am Med Assoc 281: 243–248
Lorio AM, Rivosecchi P, Zei M, Neri M and Merlett L (1989) Immune response to trivalent inactivated influenza vaccine in young and elderly subjects. Vaccine 7: 303–306
Luque R, Brieva JA, Moreno A, Manzanal A, Escribano L, Villarrubia J, Velasco JL, Lopez-Jimenez J, Cervero C, Otero MJ, Martinez J, Bellas C and Roldan, (1998) Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients–diagnostic and clinical implications. Clin Exp Immunol 112: 410–418
Lyall EGH, Charlett A, Watkins P and Zambon M (1997) Response to influenza virus vaccine in vertical HIV infection. Arch Dis Childhood 76: 215–218
Miotti PG, Nelson KE, Dalabetta GA, Farzadegan H, Margolock J and Clements ML (1989) The influence of HIV on antibody responses to a two-dose regimen of influenza vaccine. J Am Med Assoc 262: 779–783
Musto P and Carotenuto M (1997) Vaccination against influenza in multiple myeloma (letter). Br J Haematol 97: 505–506
Norden CW (1980) Infections in patients with multiple myeloma [editorial]. Arch Intern Med 140: 1150–1151
Parkkali T, Kayhty H, Ruutu T, Volin L, Eskola J and Ruutu P (1996) A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT. Bone Marrow Transplant 18: 961–996
Ringden O (1997) Allogeneic bone marrow transplantation for hematological malignancies controversies and recent advances. Acta Oncol 36: 549–564
Savage DG, Lindenbaum J and Garrett TJ (1982) Biphasic pattern of bacterial infection in multiple myeloma. Ann Intern Med 96: 47–50
Sullivan KM, Monto AS and Foster DA (1990) Antibody response to inactivated influenza vaccines of various antigenic concentrations. J Infect Dis 161: 333–333
Zuckerman MA, Wood J, Chakraverty P, Taylor J, Heath AB and Oxford JS (1991) Serological responses in volunteers to inactivated trivalent subunit influenza vaccine: antibody reactivity with epidemic influenza A and B strains and evidence of a rapid immune response. J Med Virol 33: 133–137
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Robertson, J., Nagesh, K., Jowitt, S. et al. Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer 82, 1261–1265 (2000). https://doi.org/10.1054/bjoc.1999.1088
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.1999.1088
Keywords
This article is cited by
-
Impfungen in der Hämatologie und Onkologie
best practice onkologie (2023)
-
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma
Blood Cancer Journal (2022)
-
A Review of Vaccinations in Adult Patients with Secondary Immunodeficiency
Infectious Diseases and Therapy (2021)
-
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network
Leukemia (2021)
-
Novel Immunotherapies for Multiple Myeloma
Current Hematologic Malignancy Reports (2017)
